{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T03:28:04Z","timestamp":1777865284423,"version":"3.51.4"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["MCIN \/ AEI \/10.13039\/501100011033"],"award-info":[{"award-number":["MCIN \/ AEI \/10.13039\/501100011033"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["PDI2021-1237810B\\u2013C21"],"award-info":[{"award-number":["PDI2021-1237810B\\u2013C21"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["PID2023-150779OA-I00"],"award-info":[{"award-number":["PID2023-150779OA-I00"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008812","name":"Defence Science and Technology Group","doi-asserted-by":"publisher","award":["CS-72-2019"],"award-info":[{"award-number":["CS-72-2019"]}],"id":[{"id":"10.13039\/501100008812","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015985","name":"DBT Pan-IIT Centre for Bioenergy","doi-asserted-by":"publisher","award":["BT \/PR21934\/NNT\/28\/1242\/2017"],"award-info":[{"award-number":["BT \/PR21934\/NNT\/28\/1242\/2017"]}],"id":[{"id":"10.13039\/501100015985","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["\/F\/9228\/2019\\u20132020"],"award-info":[{"award-number":["\/F\/9228\/2019\\u20132020"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005052","name":"Nano Mission","doi-asserted-by":"publisher","award":["SERB\/F\/9228\/2019\\u20132020"],"award-info":[{"award-number":["SERB\/F\/9228\/2019\\u20132020"]}],"id":[{"id":"10.13039\/501100005052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ejmech.2025.118551","type":"journal-article","created":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T19:49:08Z","timestamp":1767210548000},"page":"118551","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Rational design of heparin antagonist: Guanidine-based mimetics unveil key carbohydrate-carbohydrate interactions"],"prefix":"10.1016","volume":"305","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2842-0934","authenticated-orcid":false,"given":"Ankita","family":"Chandra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Gimeno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Pay\u00e1-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Preeti","family":"Ravindra Bhoge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virendrasinh","family":"Mahida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5421-8513","authenticated-orcid":false,"given":"Jes\u00fas","family":"Jim\u00e9nez-Barbero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4451-6338","authenticated-orcid":false,"given":"Raghavendra","family":"Kikkeri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.118551_bib1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/B978-0-12-800097-7.00003-8","article-title":"Modulation of glycan recognition by clustered saccharide patches","volume":"308","author":"Cohen","year":"2014","journal-title":"Int. Rev. Cell Mol. Biol."},{"issue":"5512","key":"10.1016\/j.ejmech.2025.118551_bib2","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1126\/science.1059820","article-title":"Chemical glycobiology","volume":"291","author":"Bertozzi","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2025.118551_bib3","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1039\/D2CC06227E","article-title":"Fluorescent glyco-gold nanocluster induced EGFR mediated targeting of cancer cells","volume":"59","author":"Chandra","year":"2023","journal-title":"Chem. Commun."},{"issue":"20","key":"10.1016\/j.ejmech.2025.118551_bib4","doi-asserted-by":"crossref","first-page":"18465","DOI":"10.1021\/acs.jmedchem.4c01772","article-title":"Immunogenic sulfated L-idose homo oligosaccharides elicit neutralizing antibody against native heparan sulfate with biomarker and therapeutic possibilities","volume":"67","author":"Vishweshwara","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118551_bib5","doi-asserted-by":"crossref","first-page":"19962","DOI":"10.1039\/D4SC06225F","article-title":"NeoMProbe: a new class of fluorescent cellular and tissue membrane probe","volume":"15","author":"Anand","year":"2024","journal-title":"Chem. Sci."},{"issue":"18","key":"10.1016\/j.ejmech.2025.118551_bib6","article-title":"The impact of nanomaterial morphology on modulation of carbohydrate\u2013protein interactions","volume":"18","author":"Bhoge","year":"2023","journal-title":"ChemMedChem"},{"issue":"7","key":"10.1016\/j.ejmech.2025.118551_bib7","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a004952","article-title":"Heparan sulfate proteoglycans","volume":"3","author":"Sarrazin","year":"2011","journal-title":"Cold Spring Harbor Perspect. Biol."},{"issue":"12","key":"10.1016\/j.ejmech.2025.118551_bib8","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1111\/jth.14606","article-title":"A synthetic heparin mimetic that allosterically inhibits factor XIa and reduces thrombosis in vivo without enhanced risk of bleeding","volume":"17","author":"Al\u2010Horani","year":"2019","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ejmech.2025.118551_bib9","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1146\/annurev-biochem-060713-035314","article-title":"Demystifying heparan sulfate\u2013protein interactions","volume":"83","author":"Xu","year":"2014","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ejmech.2025.118551_bib10","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/978-3-642-23056-1_8","article-title":"Heparin and heparan sulfate: analyzing structure and microheterogeneity","volume":"207","author":"Shriver","year":"2012","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118551_bib11","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1039\/b100916h","article-title":"Heparin and heparan sulfate: structure and function","volume":"19","author":"Rabenstein","year":"2002","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.ejmech.2025.118551_bib12","doi-asserted-by":"crossref","first-page":"5656","DOI":"10.1039\/C7OB01058C","article-title":"Targeting heparin and heparan sulfate protein interactions","volume":"15","author":"Weiss","year":"2017","journal-title":"Org. Biomol. Chem."},{"issue":"7139","key":"10.1016\/j.ejmech.2025.118551_bib13","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/nature05817","article-title":"Heparan sulphate Proteoglycans fine-tune mammalian physiology","volume":"446","author":"Bishop","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2025.118551_bib14","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1146\/annurev.cellbio.22.010605.093433","article-title":"The molecular diversity of glycosaminoglycans shapes animal development","volume":"22","author":"Bulow","year":"2006","journal-title":"Annu. Rev. Cell Dev. Biol."},{"issue":"7","key":"10.1016\/j.ejmech.2025.118551_bib15","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/nrm1681","article-title":"Heparan sulphate proteoglycans: the sweet side of development","volume":"6","author":"Hacker","year":"2005","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"4","key":"10.1016\/j.ejmech.2025.118551_bib16","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.tcb.2007.02.006","article-title":"Tinkering with heparan sulfate sulfation to steer development","volume":"17","author":"Gorsi","year":"2007","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.ejmech.2025.118551_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.carres.2023.108919","article-title":"Synergestic interplay of uronic acid and sulfation composition of heparan sulfate on molecular recognition to activity","volume":"532","author":"Bhoge","year":"2023","journal-title":"Carbohydr. Res."},{"issue":"2","key":"10.1016\/j.ejmech.2025.118551_bib18","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1369\/0022155420988661","article-title":"A systems view of the heparan sulfate interactome","volume":"69","author":"Toledo","year":"2021","journal-title":"J. Histochem. Cytochem."},{"issue":"22","key":"10.1016\/j.ejmech.2025.118551_bib19","doi-asserted-by":"crossref","first-page":"10508","DOI":"10.1128\/JVI.74.22.10508-10513.2000","article-title":"Glycosaminoglycan sulfation requirements for respiratory syncytial virus infection","volume":"74","author":"Hallak","year":"2000","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.ejmech.2025.118551_bib20","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.biocel.2006.10.014","article-title":"Syndecans in wound healing, inflammation and vascular biology","volume":"39","author":"Alexopoulou","year":"2007","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"12","key":"10.1016\/j.ejmech.2025.118551_bib21","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1021\/acschembio.9b00772","article-title":"Lost in (clinical) translation: recent advances in heparin neutralization and monitoring","volume":"14","author":"Ourri","year":"2019","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2025.118551_bib22","doi-asserted-by":"crossref","first-page":"5984","DOI":"10.1039\/C5SC01208B","article-title":"Small molecule antagonists of cell-surface heparan sulfate and heparin-protein interactions","volume":"6","author":"Weiss","year":"2015","journal-title":"Chem. Sci."},{"key":"10.1016\/j.ejmech.2025.118551_bib23","doi-asserted-by":"crossref","first-page":"9623","DOI":"10.1039\/D0SC03922E","article-title":"Heparin reversal by an oligoethylene glycol functionalized guanidinocalixarene","volume":"11","author":"Huang","year":"2020","journal-title":"Chem. Sci."},{"issue":"3","key":"10.1016\/j.ejmech.2025.118551_bib24","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/0005-2795(71)90126-7","article-title":"Association of lactoferrin with other proteins, as demonstrated by changes in electrophoretic mobility","volume":"251","author":"Hekman","year":"1971","journal-title":"Biochim. Biophys. Acta"},{"issue":"6","key":"10.1016\/j.ejmech.2025.118551_bib25","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1172\/JCI102210","article-title":"Protamine (salmine) sulphate, heparin, and blood coagulation","volume":"28","author":"Portmann","year":"1949","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejmech.2025.118551_bib26","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.thromres.2016.07.008","volume":"146","author":"Ansell","year":"2016","journal-title":"Thromb. Res."},{"issue":"9","key":"10.1016\/j.ejmech.2025.118551_bib27","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1021\/bi035933x","article-title":"Pathway for polyarginine entry into mammalian cells","volume":"43","author":"Fuchs","year":"2004","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/j.ejmech.2025.118551_bib28","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/cbic.200800493","article-title":"Heparin antagonism by polyvalent display of cationic motifs on virus-like particles","volume":"10","author":"Udit","year":"2009","journal-title":"Chembiochem"},{"issue":"3","key":"10.1016\/j.ejmech.2025.118551_bib29","first-page":"E19","article-title":"Low molecular weight protamine as nontoxic heparin\/low molecular weight heparin antidote (iii): preliminary in vivo evaluation of efficacy and toxicity using a canine model","volume":"3","author":"Lee","year":"2001","journal-title":"AAPS PharmSci"},{"issue":"1","key":"10.1016\/j.ejmech.2025.118551_bib30","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1006\/jsre.1996.0261","article-title":"A [+18RGD] protamine variant for nontoxic and effective reversal of conventional heparin and low-molecular-weight heparin anticoagulation","volume":"63","author":"Wakefield","year":"1996","journal-title":"J. Surg. Res."},{"issue":"6","key":"10.1016\/j.ejmech.2025.118551_bib31","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/jama.1958.02990060041010","article-title":"Heparin neutralization with polybrene administered intravenously","volume":"166","author":"Weiss","year":"1958","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.ejmech.2025.118551_bib32","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/0006-291X(83)90550-8","article-title":"Structure-activity relationship in heparin: a synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity","volume":"116","author":"Choay","year":"1983","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.ejmech.2025.118551_bib33","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1381\/096089204323093516","article-title":"Incomplete reversal of enoxaparin toxicity by protamine: implications of renal insufficiency, obesity, and low molecular weight heparin sulfate content","volume":"14","author":"Chawla","year":"2004","journal-title":"Obes. Surg."},{"issue":"7","key":"10.1016\/j.ejmech.2025.118551_bib34","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/MBC.0b013e3283494b3c","article-title":"Protamine reversal of low molecular weight heparin clinically effective?","volume":"22","author":"van Veen","year":"2011","journal-title":"Blood Coagul. Fibrinolysis"},{"issue":"Suppl 2","key":"10.1016\/j.ejmech.2025.118551_bib35","doi-asserted-by":"crossref","first-page":"S158","DOI":"10.1016\/S0049-3848(14)50026-6","article-title":"Potential antidotes for reversal of old and new oral anticoagulants","volume":"133","author":"Suryanarayan","year":"2014","journal-title":"Thromb. Res."},{"key":"10.1016\/j.ejmech.2025.118551_bib36","doi-asserted-by":"crossref","first-page":"234S","DOI":"10.1378\/chest.08-0673","article-title":"New antithrombotic drugs: american college of chest physicians evidence-based clinical practice guidelines (8th edition)","volume":"133","author":"Weitz","year":"2008","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.ejmech.2025.118551_bib37","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0969-2126(93)90006-3","article-title":"Structural studies of the binding of the anti-ulcer drug sucrose octasulfate to acidic fibroblast growth factor","volume":"1","author":"Zhu","year":"1993","journal-title":"Structure"},{"issue":"18","key":"10.1016\/j.ejmech.2025.118551_bib38","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.2174\/1381612003398528","article-title":"Fibroblast growth factors and their inhibitors","volume":"6","author":"Manetti","year":"2000","journal-title":"Curr. Pharm. Des."},{"issue":"2","key":"10.1016\/j.ejmech.2025.118551_bib39","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/S0006-291X(86)80253-4","article-title":"Chlorate-a potent inhibitor of protein sulfation in intact cells","volume":"141","author":"Baeuerle","year":"1986","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"10","key":"10.1016\/j.ejmech.2025.118551_bib40","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1073\/pnas.71.10.4047","article-title":"Stimulation of synthesis of free chondroitin sulfate chains by, \u03b2-D-Xylosidesin cultured cells","volume":"71","author":"Schwartz","year":"1974","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118551_bib41","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S0021-9258(17)42349-0","article-title":"Biosynthesis of heparan sulfate on beta-D-xylosides depends on aglycone structure","volume":"269","author":"Fritz","year":"1994","journal-title":"J. Biol. Chem."},{"issue":"35","key":"10.1016\/j.ejmech.2025.118551_bib42","doi-asserted-by":"crossref","first-page":"13075","DOI":"10.1073\/pnas.0805862105","article-title":"Surfen, a small molecule antagonist of heparan sulfate","volume":"105","author":"Schuksz","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.ejmech.2025.118551_bib43","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1074\/jbc.M109.066167","article-title":"Aminoquinoline surfen inhibits the action of SEVI (Semen-derived enhancer of viral infection)","volume":"285","author":"Roan","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118551_bib44","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3390\/biology1010058","article-title":"The surprising role of amyloid fibrils in HIV infection","volume":"1","author":"Castellano","year":"2012","journal-title":"Biology"},{"key":"10.1016\/j.ejmech.2025.118551_bib45","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1038\/1911378a0","article-title":"Surfen: a quinoline with oncogenic and heparin-neutralizing properties","volume":"191","author":"Hunter","year":"1961","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2025.118551_bib46","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.dyepig.2008.07.015","article-title":"Insight into the heparin\u2013toluidine blue (C.I. Basic Blue 17) interaction","volume":"80","author":"D'Ilario","year":"2009","journal-title":"Dyes Pigm."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118551_bib47","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0042-6822(03)00166-1","article-title":"Binding of a N, N\u2032-bisheteryl derivative of dispirotripiperazine to heparan sulfate residues on the cell surface specifically prevents infection of viruses from different families","volume":"311","author":"Schmidtke","year":"2003","journal-title":"Virology"},{"issue":"20","key":"10.1016\/j.ejmech.2025.118551_bib48","doi-asserted-by":"crossref","first-page":"10970","DOI":"10.1128\/JVI.00998-07","article-title":"Inhibition of transfer to secondary receptors by Heparan Sulfate-binding drug or antibody induces noninfectious uptake of human papillomavirus","volume":"81","author":"Selinka","year":"2007","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118551_bib49","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.bbagen.2013.09.023","article-title":"Small molecule inhibitors of protein interaction with glycosaminoglycans (SMIGs), a novel class of bioactive agents with anti-inflammatory properties","volume":"1840","author":"Harris","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"issue":"37","key":"10.1016\/j.ejmech.2025.118551_bib50","doi-asserted-by":"crossref","first-page":"11973","DOI":"10.1002\/anie.201806770","article-title":"Dynamic covalent identification of an efficient heparin ligand","volume":"57","author":"Corredor","year":"2018","journal-title":"Angew. Chem. Int. Ed."},{"issue":"6","key":"10.1016\/j.ejmech.2025.118551_bib51","doi-asserted-by":"crossref","first-page":"4865","DOI":"10.1021\/acs.jmedchem.1c02054","article-title":"Dynamic combinatorial optimization of In vitro and In vivo heparin antidotes","volume":"65","author":"Carbajo","year":"2022","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2025.118551_bib52","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1021\/acsptsci.4c00747","article-title":"Efficient small-molecule reversal agents for anticoagulant fondaparinux","volume":"8","author":"Carbajo","year":"2025","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"11","key":"10.1016\/j.ejmech.2025.118551_bib53","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1021\/acschembio.1c00582","article-title":"Sulfation code and conformational plasticity of L-Iduronic acid homo-oligosaccharides mimic the biological functions of heparan sulfate","volume":"16","author":"Shanthamurthy","year":"2021","journal-title":"ACS Chem. Biol."},{"issue":"11","key":"10.1016\/j.ejmech.2025.118551_bib54","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1039\/D1SC00140J","article-title":"Rational designing of glyco-nanovehicles to target cellular heterogeneity","volume":"12","author":"Jain","year":"2021","journal-title":"Chem. Sci."},{"issue":"10","key":"10.1016\/j.ejmech.2025.118551_bib55","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.1039\/D0SC05862A","article-title":"Discovery of rare sulfated N-unsubstituted glucosamine based heparan sulfate analogs selectively activating chemokines","volume":"12","author":"Jain","year":"2021","journal-title":"Chem. Sci."},{"issue":"7","key":"10.1016\/j.ejmech.2025.118551_bib56","doi-asserted-by":"crossref","DOI":"10.1002\/chem.202202622","article-title":"Sulfation of heparan and Chondroitin Sulfate ligands enables cell-specific homing of nanoprobes","volume":"29","author":"Mardhekar","year":"2023","journal-title":"Chem. Eur J."},{"issue":"9","key":"10.1016\/j.ejmech.2025.118551_bib57","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1021\/acs.orglett.0c00878","article-title":"Continuous-Flow accelerated sulfation of heparan sulfate intermediates","volume":"22","author":"Anand","year":"2020","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2025.118551_bib58","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.pnmrs.2024.10.002","article-title":"NMR investigations of glycan conformation, dynamics, and interactions","volume":"144\u2013145","author":"Angulo","year":"2024","journal-title":"Prog. Nucl. Magn. Reson. Spectrosc."},{"key":"10.1016\/j.ejmech.2025.118551_bib59","doi-asserted-by":"crossref","DOI":"10.1038\/srep29602","article-title":"Uncovering the relationship between sulphation patterns and conformation of iduronic acid in heparan sulphate","volume":"6","author":"Hsieh","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2025.118551_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.carres.2024.109079","article-title":"Synthesis and ab initio conformational investigation of a series of model sulfated \u03b1-L-iduronopyranosides","volume":"538","author":"I Tokatly","year":"2024","journal-title":"Carbohydr. Res."},{"issue":"21","key":"10.1016\/j.ejmech.2025.118551_bib61","doi-asserted-by":"crossref","first-page":"6773","DOI":"10.1021\/ja00281a052","article-title":"Evidence for conformational equilibrium of the sulfated L-iduronate residue in heparin and in synthetic heparin mono- and oligo-saccharides: NMR and force-field studies","volume":"108","author":"Ferro","year":"1986","journal-title":"J. Am. Chem. Soc."},{"issue":"2","key":"10.1016\/j.ejmech.2025.118551_bib62","first-page":"157","article-title":"Conformer populations of L-iduronic acid residues in glycosaminoglycan sequences, Carbohyd","volume":"195","author":"Ferro","year":"1990","journal-title":"Res."},{"issue":"9","key":"10.1016\/j.ejmech.2025.118551_bib63","doi-asserted-by":"crossref","first-page":"13618","DOI":"10.1021\/acsomega.9b01901","article-title":"Novel NMR avenues to explore the conformation and interactions of glycans","volume":"4","author":"Valverde","year":"2019","journal-title":"ACS Omega"},{"issue":"5","key":"10.1016\/j.ejmech.2025.118551_bib64","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/glycob\/cwh037","article-title":"Diffusion ordered spectroscopy as a complement to size exclusion chromatography in oligosaccharide an\u00e1lisis","volume":"14","author":"Groves","year":"2004","journal-title":"Glycobiology"},{"key":"10.1016\/j.ejmech.2025.118551_bib65","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.pnmrs.2019.11.002","article-title":"The interpretation of small molecule diffusion coefficients: quantitative use of diffusion-ordered NMR spectroscopy","volume":"117","author":"Evans","year":"2020","journal-title":"Prog. Nucl. Magn. Reson. Spectrosc."},{"issue":"26","key":"10.1016\/j.ejmech.2025.118551_bib66","doi-asserted-by":"crossref","first-page":"9054","DOI":"10.1021\/jo001142e","article-title":"Synthesis and Anti-HIV activity of guanidinoglycosides","volume":"65","author":"Baker","year":"2000","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2025.118551_bib67","doi-asserted-by":"crossref","first-page":"12035","DOI":"10.1021\/ja002421m","article-title":"Guanidinoglycosides: a novel family of RNA ligands","volume":"122","author":"Luedtke","year":"2000","journal-title":"J. Am. Chem. Soc."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425013169?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425013169?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T06:08:59Z","timestamp":1777529339000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425013169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":67,"alternative-id":["S0223523425013169"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118551","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rational design of heparin antagonist: Guanidine-based mimetics unveil key carbohydrate-carbohydrate interactions","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118551","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118551"}}